Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for TFX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 94.33M
March 31, 2026 49.02M
December 31, 2025 152.21M
September 30, 2025 107.63M
June 30, 2025 7.741M
March 31, 2025 73.09M
December 31, 2024 202.47M
September 30, 2024 230.98M
June 30, 2024 91.31M
March 31, 2024 110.98M
December 31, 2023 138.86M
September 30, 2023 201.16M
June 30, 2023 86.27M
March 31, 2023 84.35M
December 31, 2022 98.39M
September 30, 2022 142.56M
June 30, 2022 39.76M
March 31, 2022 62.10M
December 31, 2021 201.68M
September 30, 2021 185.38M
June 30, 2021 154.28M
March 31, 2021 110.79M
December 31, 2020 195.66M
September 30, 2020 107.48M
June 30, 2020 145.47M
Date Value
March 31, 2020 -11.46M
December 31, 2019 147.90M
September 30, 2019 131.88M
June 30, 2019 97.12M
March 31, 2019 60.17M
December 31, 2018 135.14M
September 30, 2018 121.12M
June 30, 2018 94.48M
March 31, 2018 86.64M
December 31, 2017 101.32M
September 30, 2017 121.84M
June 30, 2017 106.06M
March 31, 2017 90.67M
December 31, 2016 108.33M
September 30, 2016 119.84M
June 30, 2016 113.60M
March 31, 2016 66.71M
December 31, 2015 126.00M
September 30, 2015 66.58M
June 30, 2015 66.99M
March 31, 2015 41.23M
December 31, 2014 79.71M
September 30, 2014 88.22M
June 30, 2014 86.20M
March 31, 2014 32.43M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 209.74M
Boston Scientific Corp. 1.474B
Alphatec Holdings, Inc. 20.51M
CONMED Corp. 37.10M
DexCom, Inc. 269.20M